Tanvex BioPharma, Inc. (TPE:6541)

Tanvex BioPharma Revenue

Tanvex BioPharma had revenue of 125.34M TWD in the quarter ending September 30, 2025, with 989.60% growth. This brings the company's revenue in the last twelve months to 224.83M, up 448.96% year-over-year. In the year 2024, Tanvex BioPharma had annual revenue of 34.68M, down -43.53%.

• Revenue (ttm): 224.83M
• Revenue Growth: +448.96%
• P/S Ratio: 61.60
• Revenue / Employee: 1.12M
• Employees: 200
• Market Cap: 13.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.68M	-26.73M	-43.53%
Dec 31, 2023	61.41M	39.01M	174.11%
Dec 31, 2022	22.40M	17.00M	314.43%
Dec 31, 2021	5.41M	5.11M	1,702.00%
Dec 31, 2020	300.00K	-	-